Literature DB >> 8883024

Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura.

T H Wu1, S C Wu, T P Huang, C L Yu, C Y Tsai.   

Abstract

Urinary proteins (5 mg/ml) collected from a group of 16 patients including 13 with IgA nephropathy and 3 with Schönlein-Henoch purpura (SHP) and from a control group consisting of 6 patients with diabetic nephropathy, 5 patients with hypertensive nephrosclerosis, and 5 healthy hospital staff members were studied for the contents of interleukins (IL) 1 beta, 2, 4, 6, and 12 and tumor necrosis factor alpha (TNF-alpha). Eleven patient with IgA nephropathy or SHP (11/16) but only 1 of the controls (1/16) had TNF-alpha activity in urinary proteins (p < 0.01). The IL-1 beta activity exhibited a similar tendency but to a lesser extent (10 of 16 patients with IgA nephropathy or SHP vs. 2 of 16 with other conditions, p < 0.05). Conversely, the detection rates of IL-2, IL-4, and IL-6 in both groups were not significantly different. IL-12 was not found in any of the samples from both groups. Sera and nonpurified urine samples from the same individuals were also measured for cytokines. IL-1 beta, IL-2, IL-4, and IL-12 were absent in all these samples, but TNF-alpha was found in four of the serum samples from patients with IgA nephropathy. Urinary proteins (2 mg/ml) were analyzed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, whereby peptides of 52, 49, 45, 34, 30, and 11 kD could be demonstrated in the patients with IgA nephropathy or SHP. Urinary proteins (200 micrograms/ml from patients with IgA nephropathy or SHP exerted a mitogen-like effect on the normal human mononuclear cells, as demonstrated by 3H-thymidine incorporation. In addition, these urinary proteins (400 micrograms/ml) enhanced the proliferative activity of the cultured rat glomerular mesangial cells. The exaggerated proliferation of rat glomerular mesangial cells exerted by urine proteins from 2 patients with active disease was markedly suppressed after treatment with glucocorticoids/cyclophosphamide. These results suggest that patients with IgA nephropathy or SHP can excrete excessive amounts of TNF-alpha and IL-1 beta in the urine. The inconsistent presence of these two cytokines in urine and serum may indicate that they can be produced locally and that they are implicated in the development of mesangial inflammation and glomerular damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883024     DOI: 10.1159/000189285

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  16 in total

1.  Schisandrin B Improves the Renal Function of IgA Nephropathy Rats Through Inhibition of the NF-κB Signalling Pathway.

Authors:  Jian-Hua Qin; Jia-Ru Lin; Wen-Fei Ding; Wei-Hua Wu
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  Leptin levels in Henoch-Schönlein purpura.

Authors:  Yuksel Aliyazicioglu; Ozan Ozkaya; Husamettin Yakut; Ismail Islek; Muhlise Alvur
Journal:  Clin Rheumatol       Date:  2006-07-01       Impact factor: 2.980

3.  Effect of tumor necrosis factor alpha and vascular permeability growth factor on albuminuria in rats.

Authors:  Paul F Laflam; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2005-10-07       Impact factor: 3.714

4.  The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura.

Authors:  Tae-Sun Ha
Journal:  Pediatr Nephrol       Date:  2004-12-31       Impact factor: 3.714

5.  Production of chemokines in Kawasaki disease, Henoch-Schönlein purpura and acute febrile illness.

Authors:  Hyo Seok Chung; Hyo Young Kim; Hee Sun Kim; Hee Jung Lee; Ji Hyun Yuh; Eun Sil Lee; Kwang Hae Choi; Young Hwan Lee
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

6.  Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?

Authors:  G Rostoker; J C Rymer; G Bagnard; M Petit-Phar; M Griuncelli; Y Pilatte
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

7.  Heat shock protein 70-2 and tumor necrosis factor-α gene polymorphisms in Chinese children with Henoch-Schönlein purpura.

Authors:  Gui-Xia Ding; Chen-Hu Wang; Ruo-Chen Che; Wan-Zhen Guan; Yang-Gang Yuan; Min Su; Ai-Hua Zhang; Song-Ming Huang
Journal:  World J Pediatr       Date:  2015-11-07       Impact factor: 2.764

8.  Clinical phenotype and cytokine profile of adult IgA vasculitis with joint involvement.

Authors:  Alice Delapierre; Benjamin Terrier; Evangéline Pillebout; Pauline Baudart; Noémie Jourde-Chiche; Bertrand Lioger; Nihal Martis; Guillaume Moulis; Etienne Rivière; Noémie Le Gouellec; Loïc Raffray; Geoffrey Urbanski; Sébastien Sanges; Francois Maurier; Alban Deroux; Arsène Mekinian; Renato Monteiro; Christian Marcelli; Loïc Guillevin; Francois Maillot; Bruno Lucas; Achille Aouba; Alexandra Audemard-Verger
Journal:  Clin Rheumatol       Date:  2022-01-18       Impact factor: 3.650

9.  Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.

Authors:  Alaa S Awad; Hanning You; Ting Gao; Timothy K Cooper; Sergei A Nedospasov; Jean Vacher; Patrick F Wilkinson; Francis X Farrell; W Brian Reeves
Journal:  Kidney Int       Date:  2015-06-10       Impact factor: 10.612

10.  Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura.

Authors:  S Fessatou; P Nicolaidou; D Gourgiotis; H Georgouli; K Douros; M Moustaki; A Fretzayas
Journal:  BMC Pediatr       Date:  2008-09-02       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.